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HBeAg were co-incubated for 6h, compared to that of before
stimulation, expression of B7-H1 on CD14+ cells increased, ex-
pression of TLR2 decreased, expression of B7-H1 and PD-1 on
CD4+ and CD8+ T cells increased signiﬁcantly, expression of cos-
timulatory molecules CD28 on CD4+ cells decreased;Inﬂammatory
factor TNF-α and anti-viral cytokine IFN-γ of HBeAg-stimulated
PBMC from HBeAg-negative CHB patients, increased and reduced
respectively.
Conclusion: By up-regulating expression of B7-H1 and PD-
1,HBeAg may inhibit expression of TLR2 on CD14+ cells, reduce
expression of costimulatory molecules CD28 on T lymphocyte,
inhibit polarization of Th cells, and reduce active secretion of
anti-viral factor of patients, which leaded to function of speciﬁc
cell-mediated immunity became low, thereby clearance of virus
by T lymphocyte were suppressed, which eventually resulted in
persistence of HBV infection.
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Zheng-lin Wu*, Peng Zhuang, Xue-dong Lu, Jian Liu,
Xiao-qiang Zhong. The Fourth People’s Hospital of Shenzhen
Objective: To investigate the clinical signiﬁcance of hepatitis B
virus large protein (HBLP) detection in prediction of HBV DNA
replication and the effect of anti-viral treatment.
Methods: The Serum samples were collected from 90 patients
with HBV infection before and after anti-viral treatment. HBV
DNA level was quantitatively detected using real-time poly-
merase chain reaction. HBLP was measured by enzymelinked
immunosorbent assay (ELISA). The collected data were analyzed
by bivariate correlations method.
Results: There was no signiﬁcant difference between the de-
tectable rates of HBV DNA and HBV-LP in 90 blood samples before
treatment (p>0.05); The levels of serum HBV-LP was positively
correlated with HBV DNA copies during anti-viral treatment
(r=0.857, P=0.000). The OD value of HBV-LP and the copies of
HBV-DNA decreased in the same trend along with treatment.
Conclusion: HBLP expression can reﬂect the state of HBV DNA
replication. The decrease of HBLP and HBV-DNA during the anti-
viral treatment could estimate the HBV replication state and
predict the effect of anti-viral treatment.
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Zheng-lin Wu*, Jian Liu, Xiao-qiang Zhong, Guang-cheng Lin,
Xue-dong Lu. The Fourth People’s Hospital of Shenzhen
Objective: To see the false HBsAg negative results for serum
samples in daily work and to improve the clinical laboratory tests
quality.
Methods: Four hundreds HBsAg negative stochastic serum sam-
ples were collected from the copy tubes in daily work for
detecting hepatitis B Virus markers (HBVM) with national ELISA
reagent kits divided into 200 samples with HBsAb negative and
200 positive and put them −20° frostily. HBsAg markers were
counterchecked with other two adding kinds of national reagent
and American MONOLISA HBsAg ULTRA reagents (total 4 kinds)
at the 400 samples and ﬁltrated the positive samples. At the
last ﬁltrated samples, HBV DNA levels were doubly quantitative
analyzed with ﬂuorescence quantitative PCR (FQ-PCR) and taking
the mean results.
Results:We educed the conform HBsAg negative results from the
three kinds of national reagents but ﬁve positive results from
the American reagents in repeating HBsAg detection at the 200
HBsAb negative samples. No positive results were checked out
from the 200 HBsAb positive samples with national or foreign
reagents. The HBV DNA FQ-PCR quantitative results were all
positive but less than 500 copies/ml.
Conclusion: The sensitive level of the HBsAg routine test ELISA
reagents is generally on the low side and easily bring on the false
HBsAg negative results and the false results are more frequently
from the HBsAb negative people. This maybe connected with
occult HBV infection, we should attach importance to the HBVM
counterchecking work at these people.
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Zheng-lin Wu*, Jian Liu, Xiao-qiang Zhong, Guang-cheng Lin,
Xue-dong Lu. The Fourth People’s Hospital of Shenzhen
Objective: Detecting hepatitis B virus large surface protein
(HBLP) with serological method to ﬁltrate the occult HBV infec-
tion and study the clinical detection strategy.
Methods: Two thousands HBsAg negative stochastic serum sam-
ples were collected from the copy tubes in daily work to detect
hepatitis B Virus markers (HBVM) with national ELISA reagent kits
and put them –20° frostily. The 2000 samples were detected with
HBLP and ﬁltrated the positive samples. HBsAg markers were
doubly counterchecked with other two adding kinds of national
ELISA reagent kits (total 3 kinds) at the ﬁltrated samples. The
last samples were doubly tested again with American MONOLISA
HBsAg ULTRA reagents. HBV DNA levels were quantitative an-
alyzed with ﬂuorescence quantitative PCR (FQ-PCR) and taking
the mean results.
Results: Fifteen HBLP positive samples were detected out from
the 2000 serum samples. The conform negative results were
educed from the three kinds of national reagents but conform
positive results from the American reagents in repeating HBsAg
detection at the 15 samples. The HBV DNA FQ-PCR quantitative
results were all positive but less than 500 copies/ml.
Conclusion: The false HBsAg negative results for serum samples
are more generally from national reagents than from impor-
tations and HBLP results may be positive in these samples.
Detecting HBLP marker is propitious to ﬁltrate the occult HBV
infection. This study provided a kind of serological reference
for actively searching for the detecting strategy in occult HBV
infection ﬁeld.
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Background: Evaluation of a 3-year evolution of hepatitis B virus
in a chronically infected patient was conducted.
Methods: Clinic data and HBV DNA load(s) in serum were de-
tected at three time points (1 day, 6 month and 31 month), HBV
isolates were obtained at each time.The full-length HBV genome
was cloned and 26 clones including three time points were
randomly selected, sequenced and phylogenetically analyzed.
Results: All of the 26 clones belonged to subgenotype C2. 13 nu-
cleotides in this subset of clones were found to be different from
the published sequences of genotype C of HBV. During the 3-year
evolution, nucleotides T361A, C930A, C2351T/A2353T, C2444T
were the mutations been kept in and from minor to major while
C339T and T770C were the new point mutations at the 3rd time
point (31 month). Short fragment deletion (nt2849 to 2867) in the
preS gene became dominant at the 31-month time point and had
a trend to lead to large fragment deletion, which may produce
presumptive P/S fusion proteins or truncated preS proteins. At
the third time point, the patient’s serum ALT, HBeAg and load of
HBV DNA varied greatly.
Conclusion: The evolutionary data of HBV may provide clues for
the interpretation of the course of HBV chronic infection and
progressive pathology of liver diseases.
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